Prevention of cisplatin nephrotoxicity
Open Access
- 22 August 2015
- journal article
- review article
- Vol. 5 (1) , 57-60
Abstract
Cisplatin has a well-established role in the treatment of broad spectrum of malignancies; however its use is limited because of cisplatin-induced nephrotoxicity (CIN) which can be progressive in more than 50% of cases. The most important risk factors for CIN include higher doses of cisplatin, previous cisplatin chemotherapy, underlying kidney damage and concurrent treatment with other potential nephrotoxin agents, such as aminoglycosides, nonsteroidal anti-inflammatory agents, or iodinated contrast media. Different strategies have been offered to diminish or prevent nephrotoxicity of cisplatin. The standard approach for prevention of CIN is the administration of lower doses of cisplatin in combination with full intravenous hydration prior and after cisplatin administration. Cisplatin-induced oxidative stress in the kidney may be prevented by natural antioxidant compounds. The results of this review show that many strategies for prevention of CIN exist, however, attention to the administration of these agent for CIN is necessary.Keywords
This publication has 19 references indexed in Scilit:
- The protective effect of theophyline in cisplatin nephrotoxicitySaudi Journal of Kidney Diseases and Transplantation, 2014
- Plants antioxidants: From laboratory to clinic2013
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy ProtectantsJournal of Clinical Oncology, 2009
- Interaction of Cisplatin with the Human Organic Cation Transporter 2Clinical Cancer Research, 2008
- Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondriaCancer Chemotherapy and Pharmacology, 2007
- Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2The American Journal of Pathology, 2005
- Stress response inhibits the nephrotoxicity of cisplatinAmerican Journal of Physiology-Renal Physiology, 2005
- TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failureAmerican Journal of Physiology-Renal Physiology, 2003
- Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patientsBritish Journal of Cancer, 2003
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.Journal of Clinical Oncology, 1996